3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Glioblastoma
3
Central Nervous System Neoplasms
3
Paranasal Sinus Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Smoking
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
Fluorodeoxyglucose F18
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tanespimycin
1
romidepsin
1
pembrolizumab
1
omipalisib
1
durvalumab
1
dabrafenib
1
cediranib
1
aflibercept
1
Vorinostat
1
Thyrotropin Alfa
1
Specimen Handling
1
Sorafenib
1
Pharmacogenomic Testing
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Iodine-124
1
Gefitinib
1
Decitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Follicular
×
Celecoxib
×
Clear all
No trials found.